Latest Period
Q4 2025
Security Snapshot
CVRx, Inc. - Common Stock, $0.01 par value (CVRX) Institutional Ownership
CUSIP: 126638105
13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026
Institutions Reporting
90
Shares (Excl. Options)
15,210,504
Price
$7.10
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock, $0.01 par value
- Symbol
- CVRX on Nasdaq
- Shares outstanding
- 26,135,461
- Price per share
- $8.37
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 15,210,504
- Total reported value
- $108,000,876
- % of total 13F portfolios
- 0%
- Share change
- +234,253
- Value change
- +$1,422,903
- Number of holders
- 90
- Price from insider filings
- $8.37
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- CVRX - CVRx, Inc. - Common Stock, $0.01 par value is tracked under CUSIP 126638105.
- 90 institutions reported positions in Q4 2025.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 90 to 20 between Q4 2025 and Q1 2026.
- Reported value moved from $108,000,876 to $1,285,198.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 90 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 126638105?
CUSIP 126638105 identifies CVRX - CVRx, Inc. - Common Stock, $0.01 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 126638105:
Significant Owners of CVRx, Inc. - Common Stock, $0.01 par value (CVRX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 15% | $28,578,928 | 4,024,861 | JOHNSON & JOHNSON | 31 Dec 2025 | |||
| NEW ENTERPRISE ASSOCIATES 10 L P | 7.8% | $13,635,539 | 2,026,083 | New Enterprise Associates 10, Limited Partnership | 18 Feb 2025 | |||
| Vensana Capital I GP, LLC | 7.2% | $11,849,740 | 1,760,734 | Kirk Nielsen | 31 Dec 2024 | |||
| Cooperatieve Gilde Healthcare IV U.A. | 4.9% | $8,287,928 | 1,231,490 | Cooperatieve Gilde Healthcare IV U.A. | 04 Feb 2025 |
As of 31 Dec 2025, 90 institutional investors reported holding 15,210,504 shares of CVRx, Inc. - Common Stock, $0.01 par value (CVRX). This represents 58% of the company’s total 26,135,461 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of CVRx, Inc. - Common Stock, $0.01 par value (CVRX) together control 55% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 15% | 4,024,861 | -1.9% | 5.1% | $28,576,513 |
| NEA Management Company, LLC | 7.8% | 2,026,083 | 0% | 0.73% | $14,385,189 |
| VANGUARD GROUP INC | 4.3% | 1,120,663 | +2.8% | 0% | $7,956,707 |
| BlackRock, Inc. | 4.1% | 1,061,087 | +4.5% | 0% | $7,533,717 |
| GSK plc | 3.9% | 1,007,583 | 0% | 0.9% | $7,153,839 |
| Balyasny Asset Management L.P. | 3.1% | 814,943 | +17% | 0.01% | $5,786,095 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 2.4% | 634,639 | +77% | 0.03% | $4,505,937 |
| Parkman Healthcare Partners LLC | 1.6% | 413,018 | -16% | 0.28% | $2,932,428 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.5% | 403,949 | -0.25% | 0% | $2,869,069 |
| MORGAN STANLEY | 1.5% | 380,641 | -12% | 0% | $2,702,551 |
| STATE STREET CORP | 1.2% | 311,658 | +5.5% | 0% | $2,212,772 |
| CITADEL ADVISORS LLC | 1.2% | 305,503 | +563% | 0% | $2,169,071 |
| JANE STREET GROUP, LLC | 0.86% | 225,349 | +215% | 0% | $1,599,978 |
| GSA CAPITAL PARTNERS LLP | 0.7% | 183,531 | -17% | 0.11% | $1,303,000 |
| FourWorld Capital Management LLC | 0.69% | 180,000 | +24% | 1.2% | $1,278,000 |
| GOLDMAN SACHS GROUP INC | 0.68% | 177,598 | -12% | 0% | $1,260,946 |
| TUDOR INVESTMENT CORP ET AL | 0.6% | 157,260 | +25% | 0.01% | $1,116,546 |
| MAIRS & POWER INC | 0.55% | 142,456 | -1.7% | 0.01% | $1,011,438 |
| MILLENNIUM MANAGEMENT LLC | 0.53% | 139,202 | -39% | 0% | $988,334 |
| NORTHERN TRUST CORP | 0.53% | 137,809 | -7.7% | 0% | $978,445 |
| D. E. Shaw & Co., Inc. | 0.37% | 96,212 | +26% | 0% | $683,105 |
| UBS Group AG | 0.34% | 88,401 | -42% | 0% | $627,647 |
| Quantinno Capital Management LP | 0.29% | 75,973 | +13% | 0% | $539,408 |
| Cresset Asset Management, LLC | 0.27% | 71,802 | 0% | 0% | $509,794 |
| AlphaQuest LLC | 0.27% | 70,795 | +734% | 0.03% | $502,645 |
Institutional Holders of CVRx, Inc. - Common Stock, $0.01 par value (CVRX) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 136,117 | $1,285,198 | -$174,089 | $9.46 | 20 |
| 2025 Q4 | 15,210,504 | $108,000,876 | +$1,422,903 | $7.10 | 90 |
| 2025 Q3 | 14,003,450 | $113,001,810 | -$4,140,662 | $8.07 | 91 |
| 2025 Q2 | 14,566,804 | $85,403,778 | -$19,986,146 | $5.88 | 91 |
| 2025 Q1 | 15,971,769 | $195,337,855 | +$10,778,190 | $12.23 | 95 |
| 2024 Q4 | 15,154,273 | $192,128,165 | +$11,666,171 | $12.67 | 91 |
| 2024 Q3 | 14,208,138 | $125,172,924 | +$5,810,039 | $8.81 | 84 |
| 2024 Q2 | 13,192,379 | $158,176,281 | -$11,196,197 | $11.99 | 72 |
| 2024 Q1 | 13,441,680 | $244,665,057 | +$21,036,083 | $18.21 | 87 |
| 2023 Q4 | 12,015,323 | $377,446,209 | +$6,898,602 | $31.44 | 83 |
| 2023 Q3 | 11,953,961 | $181,343,253 | +$2,863,854 | $15.17 | 64 |
| 2023 Q2 | 11,594,427 | $179,048,989 | +$23,946,250 | $15.44 | 66 |
| 2023 Q1 | 10,400,213 | $96,928,042 | -$20,701,454 | $9.32 | 61 |
| 2022 Q4 | 10,299,118 | $188,989,468 | +$3,540,115 | $18.35 | 48 |
| 2022 Q3 | 10,529,611 | $98,240,851 | -$6,931,505 | $9.33 | 37 |
| 2022 Q2 | 10,888,954 | $65,444,210 | -$7,076,705 | $6.01 | 34 |
| 2022 Q1 | 12,073,187 | $72,317,176 | -$14,166,594 | $5.99 | 55 |
| 2021 Q4 | 12,884,491 | $157,579,777 | -$25,347,085 | $12.23 | 53 |
| 2021 Q3 | 11,758,612 | $194,426,346 | -$15,245,912 | $16.54 | 49 |
| 2021 Q2 | 13,787,189 | $386,044,000 | +$386,044,000 | $28.00 | 59 |